PRA Taiwan, a subsidiary of PRA International, has entered a strategic partnership with LSK Global Pharma Services and Mediscience Planning for the joint management of multinational clinical trials in Asia as well as related services, such as study monitoring and data management. The partnership adds to PRA’s capabilities in Asia with regulatory intelligence and investigator sites in Japan through Mediscience, and in South Korea through LSK. “We are very pleased to broaden our ...